Analysis of Nevirapine (NVP) Resistance in Ugandan Infants Who Were HIV Infected Despite Receiving Single-Dose (SD) NVP versus SD NVP Plus Daily NVP Up to 6 Weeks of Age to Prevent HIV Vertical Transmission

Church, Jessica D.; Omer, Saad B.; Guay, Laura A.; Wei Huang; Lidstrom, Jessica; Musoke, Philippa; Mmiro, Francis; Jackson, J. Brooks; Eshleman, Susan H.
October 2008
Journal of Infectious Diseases;10/1/2008, Vol. 198 Issue 7, p1075
Academic Journal
Background. Single-dose nevirapine (SD NVP) at birth plus NVP prophylaxis for the infant up to 6 weeks of age is superior to SDNVP alone for prevention of vertical transmission of human immunodeficiency virus (HIV) through breastfeeding. We analyzed NVP resistance in HIV-infected Ugandan infants who received either SD NVP or extended NVP prophylaxis. Methods. We tested plasma HIV by using a genotyping assay (ViroSeq; Celera Diagnostics), a phenotypic resistance assay (PhenoSense; Monogram Biosciences), and sensitive point mutation assay (LigAmp, for K103N, Y181C, and G190A). Results. When infants were 6 weeks old, ViroSeq detected NVP resistance in a higher proportion of infants in the extended NVP arm than in the SD NVP arm (21 of 25 [84%] vs. 12 of 24 [50%]; P = .01). Similar results were obtained with LigAmp and PhenoSense. In both study arms, infants who were HIV infected at birth frequently had NVP resistance detected. In contrast, infants in the extended NVP arm who were HIV infected after birth were more likely to have resistance detected at 6 weeks, compared with infants in the SD NVP arm. The use of extended NVP prophylaxis was also associated with detection of NVP resistance by ViroSeq at 6 months (7 of 7 [100%] infants in the extended NVP arm had resistance detected, compared with 1 of 6 [16.7%] infants in the SD NVP arm; P = .005). Conclusions. The use of extended NVP prophylaxis was associated with increased selection for and persistence of NVP resistance in HIV-infected Ugandan infants.


Related Articles

  • Can perinatal HIV infection be eliminated in the United States? Mofenson, Lynne M.; Mofenson, L M // JAMA: Journal of the American Medical Association;8/11/99, Vol. 282 Issue 6, p577 

    Editorial. Discusses the possibility of eliminating perinatal HIV infection in the United States. History of perinatal HIV infection; Various studies which have demonstrated the effect of zidovudine in lowering infection; Perinatal HIV infection in the third world; Possibility of eliminating...

  • Don't pass on HIV to your child. Mi Young Hwang; Glass, Richard M.; Molter, Jeff // JAMA: Journal of the American Medical Association;8/11/99, Vol. 282 Issue 6, p606 

    Presents a page for patient use, regarding protecting a child from HIV infection. Discussion of antiretroviral drugs, including AZT or zidovudine; Other ways of protecting a baby; Testing for HIV; Information; More.

  • Early vs deferred highly active antiretroviral therapy in HIV infected infants: a European Collaborative Cohort Study. Goetghebuer, Tessa; Haelterman, Edwige; Chenadec, Jerome Le; Dollfus, Catherine; Gibb, Diana; Boyd, Katherine; Judd, Ali; Galli, Luisa; Gabiano, Clara; Ramos, Jose; Thorne, Claire; Marczynska, Magdalena; Keiser, Olivia; Ene, Luminita; Hainaut, Marc; Scherpbier, Henriette; Wintergerst, Uwe; Schmitz, Véronique; Verweel, Gwenda; Giaquinto, Carlo // Retrovirology;2008 Supplement 1, Vol. 5, Special section p1 

    Background Without antiretroviral therapy (ART), approximately 20% of HIV-1 vertically infected infants develop severe disease manifestations before the age of 1 year and surrogate markers poorly predict infants at higher risk of rapid disease progression. Several small prospective and...

  • Surveillance of perinatal AIDS and HIV diagnoses in France. Lot, Florence; Cazein, Françoise; Pillonel, Josiane; Pinget, Roselyne; Semaille, Caroline // Retrovirology;2008 Supplement 1, Vol. 5, Special section p1 

    Background Since the use of zidovudine to reduce the mother-to-child HIV transmission, the number of children perinatally infected has dramatically declined. HIV/AIDS surveillance provides data to assess the effect of prevention on the perinatal HIV transmission. Materials and methods In France,...

  • Clearance of HIV in an Infant Infected in the Perinatal Period. Rivo, Marc // American Family Physician;7/1/1995, Vol. 52 Issue 1, p258 

    Discusses Bryson et al's study published in the March 30, 1995 issue of `New England Journal of Medicine' describing a case of an infant who cleared its previous HIV infection as seen in culture or polymerase chain reaction testing. Diagnosis of HIV infection in the mother; Seronegativity of...

  • Washington Has Severe HIV Epidemic, Report Finds.  // Clinical Infectious Diseases;1/15/2008, Vol. 46 Issue 2, piv 

    The article reports that Washington D.C. has the highest rate of AIDS and more babies are born with the virus than in other cities in the U.S. It states that people living in the area are not getting tested for HIV and show up with advanced infections that progress quickly to AIDS. It adds that...

  • III. Comparison of Newborn Screening Records and Birth Certificates to Estimate Bias in Newborn HIV Serosurveys. Pass, Kenneth A.; Schedlbauer, Lewis M.; MacCubbin, Patricia A.; Glebatis, Donna M. // American Journal of Public Health;May91, Vol. 81 Issue 5, special section p22 

    The article describes the New York State Newborn HIV Seroprevalence Study of the magnitude of the HIV epidemic among childbearing women. Implicit in the study is the assumption that newborns of all state residents are tested for HIV antibodies. Dried blood spots for HIV seroprevalence were used...

  • IV. Geographic Distribution of Newborn HIV Seroprevalence in Relation to Four Sociodemographic Variables. Morse, Dale L.; Lessner, Lawrence; Medvesky, Michael G.; Glebatis, Donna M.; Novick, Lloyd F. // American Journal of Public Health;May91, Vol. 81 Issue 5, special section p25 

    The article summarizes data on the geographic distribution of HIV seroprevalence among newborns in the New York State in relation to birth weight, maternal education, race or ethnicity, and drug abuse leading to hospitalization. In New York City, univariate correlations were found between HIV...

  • Preventing HIV Among Latino and African American Gay and Bisexual Men in a Context of HIV-Related Stigma, Discrimination, and Homophobia: Perspectives of Providers. Brooks, Ronald A.; Etzel, Mark A.; Hinojos, Ernesto; Henry, Charles L.; Perez, Mario // AIDS Patient Care & STDs;Nov2005, Vol. 19 Issue 11, p737 

    HIV-related stigma, discrimination, and homophobia impede community-based efforts to combat HIV disease among Latino and African American gay and bisexual men. This commentary highlights ways to address these social biases in communities of color in Los Angeles, California, from the perspectives...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics